Haibin Wu
-
- Immunotherapy and Immune Responses 3
-
- Glioma Diagnosis and Treatment 5
- Genetic Syndromes and Imprinting 2
-
- Cancer Immunotherapy and Biomarkers 3
-
- Pluripotent Stem Cells Research 4
-
- Liver physiology and pathology 4
-
- Growth Hormone and Insulin-like Growth Factors 3
-
- 3D Printing in Biomedical Research 3
- Cited by
- Cancer ResearchImmunologyGenetics
- Journals
- SHILAP Revista de lepidopterología (1 paper)Oncogene (1 paper)Endocrinology (1 paper)
- Partner nations
- ChinaUnited StatesMexico
In The Last Decade
Haibin Wu
28 papers receiving 509 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 101
- Immunology 134
- Genetics 57
- Oncology 145
- Molecular Biology 249
Countries citing papers authored by Haibin Wu
This map shows the geographic impact of Haibin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibin Wu more than expected).
Fields of papers citing papers by Haibin Wu
This network shows the impact of papers produced by Haibin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibin Wu. The network helps show where Haibin Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haibin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 52 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 29 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 27 | |
| 14 | 2019 | 3 | |
| 15 | 2018 | 12 | |
| 16 | 2017 | 35 | |
| 17 | 2017 | 43 | |
| 18 | 2013 | 86 | |
| 19 | 2008 | 10 | |
| 20 | 2000 | 24 |
About Haibin Wu
Haibin Wu is a scholar working on Hepatology, Immunology and Allergy and Genetics, having authored 32 papers that have together received 513 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (5 papers), Liver physiology and pathology (4 papers), Pluripotent Stem Cells Research (4 papers), Immunotherapy and Immune Responses (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), 3D Printing in Biomedical Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Genetic Syndromes and Imprinting (2 papers). The work is most often cited by research in Cancer Research (101 citations), Immunology (134 citations) and Genetics (57 citations). Haibin Wu has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Ting Sun, Yanyan Li, Youxin Zhou, Yao Lin, Ziwei Du, Xuetao Li, Matthew M. Rechler, Zhitong Deng, Desheng Lu and Hao Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, Oncogene and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.